Pharmaceutical Executive, Oct 1, 2010 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Oct 1, 2010
Features
Roche Sets a New Social Media Standard
By Julian Upton
Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?
When the Payer IS the Player
By Walter Armstrong
As Medicare, Medicaid, and the nation's web of private payers gain market power, how can pharma stay ahead of the cost-containment curve?
Nobel Laureate Elie Wiesel Exclusive Interview
By William Looney
Ethical behavior can be a bridge-builder in an era where Big Pharma needs to find new partners. Is it up to the challenge?
Knowledge-Based Outsourcing: Driving Deeper Insights
By Tim Kelly , Chris Nickum
Tracking, monitoring, and trend evaluation is not enough. Companies must now do more than assess what happened and why.
Columns
Getting Ready for Sunshine
By Jill Wechsler
Health reform requires detailed tracking and full disclosure of fees to docs for marketing and research
Taking a Less-Generic Route to Generics
By Tim Wright
A leading industry player speaks out on what is fueling success in the sector
Euro Soul-Searching on Competition
By Reflector
A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers
Roles, Resources In Conflict
Data shows training and development is ignored where it may count most
Digital Alternatives Define New Sales Force
By Bill Cooney
Teams must adapt techniques to embrace new technologies in order to remain successful
Pharmacies are Our Friends
By Justin McCarthy
An underutilized sales resource, pharmacies and their staffs can help lead to improved scrip fulfillment and increased business
Decisive Strategy Wins the Market
By Stan Bernard, MD
A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way
Pharm Exec Special Section (Features)
Optimizing TV Advertising Placements & Results
Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives
From the Editor
Community: The Business of Life
By William Looney
Adam Smith's theory of the uncompromising market may set the tone for today's capitalism, but we forget that his first work,"The Theory of Moral Sentiments," made 'bettering the human condition' the basis from which all productive commerce flows.

ADVERTISEMENT

Click here